A
Aki Hirabayashi
Researcher at National Institutes of Health
Publications - 39
Citations - 314
Aki Hirabayashi is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Plasmid & Medicine. The author has an hindex of 6, co-authored 32 publications receiving 104 citations. Previous affiliations of Aki Hirabayashi include Nagoya University.
Papers
More filters
Journal ArticleDOI
National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.
Shinya Tsuzuki,Nobuaki Matsunaga,Koji Yahara,Yoshiaki Gu,Kayoko Hayakawa,Aki Hirabayashi,Toshiki Kajihara,Motoyuki Sugai,Keigo Shibayama,Norio Ohmagari +9 more
TL;DR: This study provides the first annual estimate of disease burden of BSI caused by antimicrobial resistant (AMR) bacteria in Japan, and basis for formulating health policy to deal with AMR.
Journal ArticleDOI
Long-read metagenomics using PromethION uncovers oral bacteriophages and their interaction with host bacteria
Koji Yahara,Masato Suzuki,Aki Hirabayashi,Wataru Suda,Masahira Hattori,Yutaka Suzuki,Yusuke Okazaki +6 more
TL;DR: In this paper, the authors conduct a long-read metagenomic study of human saliva using PromethION, which integrates both Promethion and HiSeq data of >30Gb per sample with low human DNA contamination, identify hundreds of viral contigs; 0-43.8%, 12.5-56.3%, and 86.4% of the genes as core and singletons, respectively.
Journal ArticleDOI
The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot study.
Hiroshi Morioka,Aki Hirabayashi,Mitsutaka Iguchi,Yuka Tomita,Daizo Kato,Naokazu Sato,Miyuki Hyodo,Naoko Kawamura,Takuya Sadomoto,Kazuya Ichikawa,Takayuki Inagaki,Yoshiaki Kato,Yuichi Kouyama,Yoshinori Ito,Tetsuya Yagi +14 more
TL;DR: The incidence of HAIs is higher in Japan than in other developed countries, and the social and medical situation in Japan may affect patient demographics, active HAIs, and antimicrobial use.
Journal ArticleDOI
Japan Nosocomial Infections Surveillance (JANIS): Current Status, International Collaboration, and Future Directions for a Comprehensive Antimicrobial Resistance Surveillance System
TL;DR: JANIS further continues to evolve in multiple directions, some of which are selected and discussed in end of this review.
Journal ArticleDOI
Impact of the COVID-19 pandemic on the surveillance of antimicrobial resistance.
TL;DR: In this article, the authors compared the number of patients and isolation rate of five bacteria between 2019 and 2020, including antimicrobial-susceptible and resistant bacteria of Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa.